Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment-Reference-Cited by-同舟云学术

Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatment

Published:2015-11-24 Issue:12 Volume:30 Page:1775-1781
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Shin Seung Kak¹,Kim Jeong Han²,Park Hyeonsu¹,Kwon Oh Sang¹,Lee Hyun Jung³,Yeon Jong Eun³,Byun Kwan Soo³,Suh Sang Jun⁴,Yim Hyung Joon⁴,Kim Yun Soo¹,Kim Ju Hyun¹

Affiliation:

1. Department of Internal Medicine; Gachon University Gil Medical Center; Incheon South Korea

2. Department of Internal Medicine; Konkuk University School of Medicine; Seoul South Korea

3. Department of Internal Medicine; Korea University Guro Hospital; Seoul South Korea

4. Department of Internal Medicine; Korea University Ansan Hospital; Ansan South Korea

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13020/fullpdf

Reference42 articles.

1. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

2. Revision and update on clinical practice guideline for liver cirrhosis;Suk;Korean J. Hepatol.,2012

3. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

4. Natural history and prognostic factors for chronic hepatitis type B;Fattovich;Gut,1991

5. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance;Andreone;J. Viral Hepat.,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of the Fibrosis‐4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patients;Hepatology Research;2023-09-06

2. A Comprehensive Hepatitis B Surface Antigen-Positive Patient-Centered Screening and Linkage to Care Strategies Targeting Microelimination of Hepatitis C Virus Infection in Chongqing, China;Canadian Journal of Gastroenterology and Hepatology;2022-12-27

3. A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients;Journal of Korean Medical Science;2022

4. The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection;Problems of Virology;2021-11-04

5. Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Associated Cirrhosis;Gut and Liver;2021-05-15